The strongest predictor of colorectal cancer screening participation may be a specific, personalized communication from a patient’s own healthcare provider, according to a study led by researchers at Renton, Wash.-based Providence and published April 24 in Cancer Medicine. “We thought…
Author: Elizabeth Gregerson
When compared to chemotherapy, a drug targeting oncogenic RAS mutations extended overall and progression-free survival for patients with metastatic pancreatic cancer, according to a study published May 31 in The New England Journal of Medicine. The third-leading cause of cancer…
An androgen receptor inhibitor was found to improve rates of metastasis-free survival among prostate cancer patients when combined with androgen deprivation therapy, according to a study published May 31 in The New England Journal of Medicine. The study was led…
Seattle-based Fred Hutch Cancer Center has appointed Nida Shekhani executive vice president and chief strategy and clinical growth officer. Ms. Shekhani will step into the role July 1, according to a June 3 LinkedIn post from the cancer center. She…
New York City-based Memorial Sloan Kettering Cancer Center has appointed Martin Weiser, MD, chair of the department of surgery. Dr. Weiser joined Memorial Sloan Kettering 25 years ago and has served as acting department chair for the past 10 months,…
Advertisement
In April, the FDA debuted a real-time clinical trial model that will allow the agency to monitor safety signals as the trial is being conducted. The first trials were launched in partnership with Houston-based University of Texas MD Anderson Cancer…
Norfolk, Va.-based Sentara Health will launch the first vertically integrated theranostics program in Virginia. The program will be established in partnership with biotechnology firm BAMF Health, according to a May 28 news release from Sentara Health. Theranostics offers treatment for…
A personalized mRNA cancer vaccine combined with immunotherapy cut melanoma recurrence risk by 49%, according to a study published June 1 in the Journal of Clinical Oncology and simultaneously presented at the American Society of Clinical Oncology annual meeting in…
Salt Lake City-based Huntsman Cancer Institute at the University of Utah has launched a care affiliation with Portneuf Cancer Center, part of Pocatello, Idaho-based Portneuf Medical Center. Through the partnership, Portneuf Cancer Center will integrate Huntsman Cancer Institute’s clinical expertise…
Health systems across the U.S. have experienced an uptake in patient demand for the pancreatic cancer drug daraxonrasib in the weeks since the FDA granted expanded access to the drug through a May 1 “safe to proceed” letter. Demand heightened…